Gilead's two hepatitis C drug trials meet study goals

[riky]

Gilead's two hepatitis C drug trials meet study goals

(Reuters) - Biotechnology company Gilead Sciences on Monday said two trials of its hepatitis C drug, the centerpiece of its oral hepatitis C treatment program, met their goals in two late-stage studies. The results are expected to be used to support the company's regulatory filing seeking approval in the United States. Industry analysts say the market for such drugs could reach $25 billion by 2020. An estimated 4 million Americans have the virus, with 170 million infected worldwide. ...

Source: You are not allowed to view links. Register or Login